Nektar Therapeutics (ITH.F) Q2 2024 Earnings

May 9Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.2
-0.19
-0.19
-0.18

Details

Expected EPS
-0.17616800000000002
Actual EPS
-0.17616800000000002
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Nektar Therapeutics⁩ (⁦ITH.F⁩) has reported earnings of ⁦-0.17616800000000002⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts